FDA approves Pfizer vaccine for emergency use in children aged 5 to 11

The U.S. Food and Drug Administration approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in children aged 5 to 11 on Friday, a critical step toward beginning vaccinations for the age group. "The FDA has determined this Pfizer vaccine has met the criteria for emergency use authorization," the FDA said in a press release. "Based on the totality of scientific evidence available, the known and potential benefits of the Pfizer-BioNTech COVID-19 vaccine in individuals down to 5 years of age outweigh the known and potential risks. -- More...

---

---